Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Sees Large Increase in Short Interest

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 103,300 shares, a growth of 225.9% from the February 13th total of 31,700 shares. Based on an average trading volume of 487,700 shares, the short-interest ratio is presently 0.2 days. Currently, 0.0% of the shares of the company are sold short.

Analysts Set New Price Targets

A number of research firms have recently issued reports on RBGLY. Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th. Barclays lowered shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a report on Tuesday, February 4th. HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Finally, Royal Bank of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Three research analysts have rated the stock with a hold rating, two have given a buy rating and three have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Reckitt Benckiser Group presently has an average rating of “Buy”.

View Our Latest Stock Analysis on RBGLY

Reckitt Benckiser Group Stock Down 1.7 %

Shares of Reckitt Benckiser Group stock traded down $0.23 during mid-day trading on Friday, reaching $13.33. 321,920 shares of the stock were exchanged, compared to its average volume of 311,617. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a fifty-two week low of $10.24 and a fifty-two week high of $14.10. The firm has a 50-day simple moving average of $12.95 and a 200 day simple moving average of $12.46.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.